An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus

被引:384
作者
James, JA
Kaufman, KM
Farris, AD
Taylor-Albert, E
Lehman, TJA
Harley, JB
机构
[1] Univ Oklahoma, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA
[3] Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA
[4] Hosp Special Surg, New York, NY 10021 USA
关键词
autoimmunity; autoantibodies; viral infection; autoimmune disease; SLE;
D O I
10.1172/JCI119856
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
An unknown environmental agent has been suspected to induce systemic lupus erythematosus (lupus) in man. Prompted by our recent immunochemical findings, we sought evidence for an association between Epstein-Barr virus infection and lupus. Because the vast majority of adults have been infected with Epstein-Barr virus, we chose to study children and young adults, Virtually all (116 of 117, or 99%) of these young patients had seroconverted against Epstein-Barr virus, as compared with only 70% (107 of 153) of their controls (odds ratio 49.9, 95% confidence interval 9.3-1025, P < 0.00000000001). The difference in the rate of Epstein-Barr virus seroconversion could not be explained by serum IgG level or by cross-reacting anti-Sm/nRNP autoantibodies. No similar difference was found in the seroconversion rates against four other herpes viruses, An assay for Epstein-Barr viral DNA in peripheral blood lymphocytes established Epstein-Parr virus infection in the peripheral blood of all 32 of the lupus patients tested, while only 23 of the 32 matched controls were infected (odds ratio > 10, 95% confidence interval 2.53-infinity, P < 0.002), When considered with other evidence supporting a relationship between Epstein-Barr virus and lupus, these data are consistent with, but do not in themselves establish, Epstein-Barr virus infection as an etiologic factor in lupus.
引用
收藏
页码:3019 / 3026
页数:8
相关论文
共 36 条
  • [1] GENETIC-STUDIES OF RO (SS-A) AND LA (SS-B) AUTOANTIBODIES IN FAMILIES WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND PRIMARY SJOGRENS SYNDROME
    ARNETT, FC
    HAMILTON, RG
    REVEILLE, JD
    BIAS, WB
    HARLEY, JB
    REICHLIN, M
    [J]. ARTHRITIS AND RHEUMATISM, 1989, 32 (04): : 413 - 419
  • [2] EVANS AS, 1971, LANCET, V1, P167
  • [3] EVANS AS, 1989, VIRAL INFECT HUMANS, P265
  • [4] ACTIVATION OF EPSTEIN-BARR-VIRUS LATENT GENES PROTECTS HUMAN B-CELLS FROM DEATH BY APOPTOSIS
    GREGORY, CD
    DIVE, C
    HENDERSON, S
    SMITH, CA
    WILLIAMS, GT
    GORDON, J
    RICKINSON, AB
    [J]. NATURE, 1991, 349 (6310) : 612 - 614
  • [5] EPSTEIN-BARR VIRUS-CODED BHRF1 PROTEIN, A VIRAL HOMOLOG OF BCL-2, PROTECTS HUMAN B-CELLS FROM PROGRAMMED CELL-DEATH
    HENDERSON, S
    HUEN, D
    ROWE, M
    DAWSON, C
    JOHNSON, G
    RICKINSON, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) : 8479 - 8483
  • [6] James JA, 1996, J IMMUNOL, V156, P4018
  • [7] Lupus humoral autoimmunity after short peptide immunization
    James, JA
    Scofield, RH
    Harley, JB
    [J]. B LYMPHOCYTES AND AUTOIMMUNITY, 1997, 815 : 124 - 127
  • [8] JAMES JA, 1992, J IMMUNOL, V148, P2074
  • [9] IMMUNOGLOBULIN EPITOPE SPREADING AND AUTOIMMUNE-DISEASE AFTER PEPTIDE IMMUNIZATION - SM B/B'-DERIVED PPPGMRPP AND PPPGIRGP INDUCE SPLICEOSOME AUTOIMMUNITY
    JAMES, JA
    GROSS, T
    SCOFIELD, RH
    HARLEY, JB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 453 - 461
  • [10] JAMES JA, 1994, CLIN EXP IMMUNOL, V98, P419